Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease -: A case-control study

被引:70
作者
Snaedal, J [1 ]
Kristinsson, J
Gunnarsdóttir, S
Olafsdóttir, A
Baldvinsson, M
Jóhannesson, T
机构
[1] Reykjavik Hosp, Dept Geriatr, IS-101 Reykjavik, Iceland
[2] Univ Iceland, Dept Pharmacol, Reykjavik, Iceland
[3] Univ Iceland, Fac Med, Reykjavik, Iceland
关键词
Alzheimer's disease; copper; ceruloplasmin; superoxide dismutase; free radicals;
D O I
10.1159/000017067
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The copper-containing enzyme superoxide dismutase (SOD) is a key enzyme in suppressing the amounts of superoxide anion radicals. Ceruloplasmin, the copper-transporting protein in plasma, also possesses an important redox capacity. In this study the levels of copper and ceruloplasmin as well as SOD-activity and ceruloplasmin oxidative activity were analyzed in order to throw some light on possible defects in copper mechanisms in patients diagnosed with Alzheimer's disease (AD). The study included 44 patients with AD and their healthy age- and gender-matched controls. No difference of significance was seen when comparing the copper or ceruloplasmin concentration in plasma of AD patients to that of their paired controls. The SOD activity in red blood cells was significantly lower in the patients than in their controls (p = 0.019). The ceruloplasmin oxidative activity in plasma of Alzheimer's patients was greatly reduced as compared to that of age- and gender-matched controls and the difference was highly significant (p = 0.0005). Ceruloplasmin activity and SOD activity were not found to be intrinsically correlated, It was postulated that reduced oxidative activity of ceruloplasmin in plasma might be either a cause or a consequence of AD and that reduced SOD activity might further add to the oxidative disturbances in AD due to defective ceruloplasmin activity.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 21 条
[1]  
ANDERSEN V, 1996, NORD MED, V11, P230
[2]  
BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231
[3]   AUTOMATED-ASSAY OF CERULOPLASMIN BY KINETIC-ANALYSIS OF ORTHO-DIANISIDINE OXIDATION [J].
BOYETT, JD ;
LEHMANN, HP ;
BEELER, MF .
CLINICA CHIMICA ACTA, 1976, 69 (02) :233-241
[4]   CERULOPLASMIN LEVELS IN THE HUMAN SUPERIOR TEMPORAL GYRUS IN AGING AND ALZHEIMERS-DISEASE [J].
CONNOR, JR ;
TUCKER, P ;
JOHNSON, M ;
SNYDER, B .
NEUROSCIENCE LETTERS, 1993, 159 (1-2) :88-90
[5]   COPPER-ZINC SUPEROXIDE-DISMUTASE ACTIVITY IN RED-BLOOD-CELLS AND SERUM IN DEMENTED PATIENTS AND IN AGING [J].
DELUSTIG, ES ;
SERRA, JA ;
KOHAN, S ;
CANZIANI, GA ;
FAMULARI, AL ;
DOMINGUEZ, RO .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 (01) :18-25
[6]   FREE-RADICALS IN BRAIN METABOLISM AND PATHOLOGY [J].
EVANS, PH .
BRITISH MEDICAL BULLETIN, 1993, 49 (03) :577-587
[7]  
Goyer R.A., 1996, CASARETT DOULLS TOXI
[8]  
HALLIWELL B, 1989, FREE RADICAL BIO MED, P44
[9]   A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE [J].
HENSLEY, K ;
CARNEY, JM ;
MATTSON, MP ;
AKSENOVA, M ;
HARRIS, M ;
WU, JF ;
FLOYD, RA ;
BUTTERFIELD, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3270-3274
[10]  
KJELD M, 1987, LAEKNABLADID, V73, P335